GlassScriptPhysician profile
Sankar N Adusumilli
NPI 1639161227
$2,510.61
in general payments reported to CMS, 2019-2025
31 companies · $313 in 2025
The $313 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $721 · 2020: $402 · 2021: $342 · 2022: $268 · 2023: $303 · 2024: $163 · 2025: $313.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $779.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $778.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $608.82 | 2019 | |
| Davol INC. | $324.21 | 2021-2025 | Phasix Mesh, Arista |
| Musculoskeletal Transplant Foundation INC. | $210.53 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $200.85 | 2022-2025 | Gattex |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $156.44 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $112.56 | 2021-2024 | Clenpiq |
| Axonics, INC. | $86.79 | 2020-2023 | Axonics |
| Integra Lifesciences Corporation | $83.43 | 2022-2025 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Merck Sharp & Dohme LLC | $76.13 | 2020-2025 | Zerbaxa |
| Medtronic, INC. | $68.22 | 2021-2025 | Interstim |
| Baxter Healthcare | $63.85 | 2020-2023 | Floseal |
| Aroa Biosurgery Incorporated | $51.51 | 2022 | |
| Tela Bio, INC. | $47.39 | 2022-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Hologic Sales and Service, LLC | $42.69 | 2024 | Coolseal Generator |
| Ethicon US, LLC | $42.04 | 2019-2020 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stimlabs LLC | $40.59 | 2025 | Corplex P |
| Braintree Laboratories, INC. | $36.69 | 2021-2022 | |
| Vioptix INC | $31.99 | 2020 | |
| Tetraphase Pharmaceuticals, INC. | $27.25 | 2019 | |
| Abbvie INC. | $26.93 | 2025 | |
| Amgen INC. | $21.50 | 2025 | Uplizna |
| Pacira Pharmaceuticals Incorporated | $18.70 | 2024 | Zilretta, Iovera, Exparel |
| Smith+Nephew, INC. | $18.35 | 2019 | |
| La Jolla Pharmaceutical Company | $16.98 | 2024 | Xerava |
| Ambu INC. | $16.06 | 2022 | |
| Teleflex LLC | $15.55 | 2020 | |
| Myriad Genetic Laboratories, INC. | $15.02 | 2024 | Myrisk |
| Allergan, INC. | $13.77 | 2019 | |
| Medtronic USA, INC. | $12.88 | 2020 | |
| Thd America, INC. | $11.96 | 2021 | |
| Coopersurgical, INC. | $10.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sankar Adusumilli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.